Cullinan Therapeutics, Inc. (CGEM)

Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $771.10 million. The enterprise value is $395.89 million.

Market Cap	771.10M
Enterprise Value	395.89M

Important Dates

The last earnings date was Tuesday, March 10, 2026, before market open.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

CGEM has 60.53 million shares outstanding. The number of shares has increased by 9.82% in one year.

Current Share Class	60.53M
Shares Outstanding	60.53M
Shares Change (YoY)	+9.82%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	77.49%
Float	43.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.88
P/TBV Ratio	1.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.01.

Current Ratio	10.25
Quick Ratio	10.09
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.02% and return on invested capital (ROIC) is -314.90%.

Return on Equity (ROE)	-44.02%
Return on Assets (ROA)	-28.22%
Return on Invested Capital (ROIC)	-314.90%
Return on Capital Employed (ROCE)	-58.85%
Weighted Average Cost of Capital (WACC)	3.37%
Revenue Per Employee	n/a
Profits Per Employee	-$2.02M
Employee Count	109
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.28% in the last 52 weeks. The beta is -0.16, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	+47.28%
50-Day Moving Average	12.96
200-Day Moving Average	9.43
Relative Strength Index (RSI)	40.55
Average Volume (20 Days)	848,829

Short Selling Information

The latest short interest is 8.08 million, so 13.35% of the outstanding shares have been sold short.

Short Interest	8.08M
Short Previous Month	8.02M
Short % of Shares Out	13.35%
Short % of Float	18.70%
Short Ratio (days to cover)	10.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-241.65M
Pretax Income	-219.88M
Net Income	-219.88M
EBITDA	-241.34M
EBIT	-241.65M
Earnings Per Share (EPS)	-$3.72

Balance Sheet

The company has $377.90 million in cash and $2.68 million in debt, with a net cash position of $375.21 million or $6.20 per share.

Cash & Cash Equivalents	377.90M
Total Debt	2.68M
Net Cash	375.21M
Net Cash Per Share	$6.20
Equity (Book Value)	408.73M
Book Value Per Share	6.78
Working Capital	349.02M

Cash Flow

In the last 12 months, operating cash flow was -$175.75 million and capital expenditures -$49,000, giving a free cash flow of -$175.80 million.

Operating Cash Flow	-175.75M
Capital Expenditures	-49,000
Depreciation & Amortization	311,000
Net Borrowing	n/a
Free Cash Flow	-175.80M
FCF Per Share	-$2.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.82%
Shareholder Yield	-9.82%
Earnings Yield	-28.51%
FCF Yield	-22.80%

Analyst Forecast

The average price target for CGEM is $30.11, which is 136.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.11
Price Target Difference	136.34%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-5.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1